clinical trials for retatrutide trial sign up Eli Lilly infiltrates anti-obesity market as Phase III begins Retatrutide Dosage: What Clinical Trial – Clinical trials of subcutaneous tirzepatide

Liraglutide as add-on to sodium-glucose co-transporter-2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial

doi: 10.1016/j.ejphar.2020.173581 124 Barreto-ViannaARCAguilaMBMandarim-de-LacerdaCA

Improved side effects : Many patients report that nausea and bloating are noticeably better by week three

Important limitations of this study are that it was conducted only in a Japanese population, with a short follow-up time of 2 years and in a group of patients with very little progression of renal disease, since the drop of eGFR in the placebo group was less than 1 ml/min/year

Xi H, Langerman J, Sabri S, Chien P, Young CS, Younesi S, et al